The 24 references in paper А. Добровольский Б., Е. Титаева В., А. Добровольский Б., Е. Титаева В. (2013) “ОБРАЗОВАНИЕ ТРОМБИНА И ЕГО ФУНКЦИИ В СИСТЕМЕ ГЕМОСТАЗА” / spz:neicon:aterotromboz:y:2013:i:1:p:66-72

1
Davie E. W., Ratnoff O. D. Waterfall sequence for intrinsic blood clotting//Science. 1964. No 145. Р. 1310–1312.
(check this in PDF content)
2
MacFarlane R. G. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier//Nature. 1964. No 202. Р. 498–499.
(check this in PDF content)
3
Furie B., Furie B. C. Molecular and cellular biology of blood coagulation//N. Engl. J. Med. 1992. No 326. Р. 800–806.
(check this in PDF content)
4
Бутенас С., Манн К. Г. Свертывание крови (обзор)//Биохимия. 2002. No 67. Р. 5–15.
(check this in PDF content)
5
Heemskerk J. W. M., Mattheij N. J. A., Cosemans J. M. E. M. Platelet-based coagulation: different populations, different functions//J. Thromb. Haemost. 2013. No 11. Р. 2–16.
(check this in PDF content)
6
Hoffman M., Monroe III D. M. A cell-based model of hemostasis//Thromb. Haemost. 2001. No 85. Р. 958–965.
(check this in PDF content)
7
Heemskerk J. W. M., Mattheij N. J. A., Cosemans J. M. M. Platelet-based coagulation: different populations, different functions//J. Thromb. Haemost. 2013. No 11. Р. 2–16.
(check this in PDF content)
8
Cawthern K. M., van ‘t Veer C., Lock J. B., DiLorenzo M. E., Branda R. F., Mann K. G. Blood Coagulation in Hemophilia A and Hemophilia C//Blood. 1998. Vol.
(check this in PDF content)
9
No 12 (June 15). P. 4581–4592. 9. Choi S. H., Smith S. A., Morissey J. H. Polyphosphate is a cofactor for the activation of factor XI by thrombin//Blood. 2011. No 118. Р. 6963–6970.
(check this in PDF content)
10
Furie B., Furie B. C. In vivo thrombus formation//J. Thromb. Haemost. 2007. No 5 (Supll.1). Р. 12–17.
(check this in PDF content)
11
Wang X., Cheng Q., Xu L., Feuerstein G. Z., Hsu M.-Y., Smith P. L., Seiffert D. A., Schumacher W. A., Ogletree M. L., Gailani D. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice//J. Thromb. Haemost. 2005. No 3. Р. 695–702.
(check this in PDF content)
12
Peraramelli S., Jan Rosing J., Hackeng T. M. TFPIdependent activities of Protein S//Thromb. Res. 2012. No 129. S. 23–26.
(check this in PDF content)
13
Kasthuri R. S., Glover S. L., Boles J., Mackman N. Tissue Factor and Tissue Factor Pathway Inhibitor as Key Regulators of Global Hemostasis: Measurement of Their Levels in Coagulation Assays//Semin. Thromb. Hemost. 2010. No 36. Р. 764–771.
(check this in PDF content)
14
Mann K. G., Brummel K., Butenas S. What is all that thrombin for?//J. Thromb. Haemost. 2003. No 1. Р. 1504–1514.
(check this in PDF content)
15
Muszbek L., Bereczky Z., Bagoly Z., Komáromi I., Katona E. Factor XIII: A Coagulation Factor With Multiple Plasmatic and Cellular Functions//Physiol. Rev. 2011. No 91. Р. 931–972.
(check this in PDF content)
16
Foley J. H., Nesheim M. E., Rivard G. E., BrummelZiedins K. E. Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A// Haemophilia. 2012. No 18 (3). e316–322.
(check this in PDF content)
17
Colucci M., Semeraro N. Thrombin activatable fibrinolysis inhibitor: At the nexus of fibrinolysis and inflammation//Thromb. Res. 2012. No 129. Р. 314–319.
(check this in PDF content)
18
Incampo F., Carrieri C., Galasso R., Scaraggi F. A., di Serio F., Woodhams B., Semeraro N., Colucci M. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFImediated inhibition of fibrinolysis//J. Thromb. Haemost. 2013. No 11. Р. 315–324.
(check this in PDF content)
19
Wolberg A. S. Thrombin generation and fibrin clot structure//Blood Reviews. 2007. No 21. Р. 131–142.
(check this in PDF content)
20
Collet J.-P., Montalescot G., Lesty C., Weisel J. W. A structural and dynamic investigation of the facilitating effect of glycoportein IIb/ IIIa inhibitors in dissolving platelet-rich clots//Circ. Res. 2002. No 90. Р. 428–434.
(check this in PDF content)
21
Siller-Matula J. M., Schwameis M., Blann A., Mannhalter C., Jilma B. Thrombin as a multifunctional enzyme: Focus on in vitro and in vivo effects//Thromb. Haemost. 2011. No 106. Р. 1020–1033.
(check this in PDF content)
22
Cattaneo M. Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?//J. Thromb. Haemost. 2012. No 10. Р. 327–336.
(check this in PDF content)
23
Сироткина О. В., Вавилова Т. В. Алгоритм лабораторного молекулярно-генетического исследования для определения индивидуальной чувствительности к антиагрегантным препаратам – шаг навстречу персонализированной медицине//Атеротромбоз. 2012. No 1. Р. 49–55.
(check this in PDF content)
24
Комаров А. Л., Шахматова О. О., Илющенко Т. А., Донников А. Е., Добровольский А. Б., Панченко Е. П. Оценка риска сердечно-сосудистых осложнений у больных стабильной ИБС, получающих клопидогрел: функция тромбоцитов
(check this in PDF content)